This is a working overview of Nuclear receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-05. Anything still debated is marked as such rather than presented as settled.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
HCO2H → H2O + CO Treatment of formic acid with sulfuric acid is a convenient laboratory source of CO. A similar reaction is also possible with other mineral oxyacids, but not fluoroacids (e.g. hydrogen tetrafluoroborate in anhydrous hydrogen fluoride). The difference has been ascribed to a transition state stabilized by hydrogen bonding with the acid oxygens. An unstable formic anhydride, H(C=O)−O−(C=O)H, can be obtained by dehydration of formic acid with N,N′-dicyclohexylcarbodiimide in ether at low temperature. Contrariwise, mixed anhydrides are generally stable formylating agents.
=== Background and theme === On January 9, 2020, American Horror Story was renewed for up to a thirteenth season. On December 5, 2018, Ryan Murphy said the witches from Coven would return in a future season. On July 28, 2026, Murphy announced in an interview with Entertainment Tonight that the season, officially titled 13, would consist of 13 episodes, and while the season would revisit Coven, it was not a direct sequel. He desribed it as an Avengers-style crossover between "all the seasons", with characters coming together "to defeat the ultimate evil", and added that he spent years writing it. Leslie Grossman explained that the series was set in one universe with different timelines, which "intersect in a way that makes sense". The theme of the number 13 was announced alongside the title. The show's official FX page for the season reads: "FX's American Horror Story ... returns for an unrivaled 13th installment that will do justice to everyone's most feared number. ... Which iconic horrors will return to haunt the hallowed halls of 13 and what new terrors await? Light your candles, draw your pentagrams and prepare for a supreme surprise." In August 2026, Murphy revealed he would direct an episode, for the first time since "Checking In" (2015). In September 2026, he said that the crossover with Scream Queens was planned to be included in the season, but it was scrapped after the departure of Ariana Grande, who was supposed to reprise her role as Chanel #2.
== MHC class II and Type I diabetes == MHC class II genes and molecules are related to a multitude of different diseases, one of which being Type I diabetes. HLA class II genes are the most important genes associated with the risk of inheriting Type I diabetes, accounting for about 40-50% of heritability. Alleles of these genes that affect peptide binding to the MHC class II molecules seem to impact Type I diabetes risk the most. Specific allele polymorphisms have been identified to increase the risk (such as DRB1 and DQB1). Others have been associated with a resistance to the disease.
Sources: en.wikipedia.org
== Common biopolymers == Collagen: Collagen is the primary structure of vertebrates and is the most abundant protein in mammals. Because of this, collagen is one of the most easily attainable biopolymers, and used for many research purposes. Because of its mechanical structure, collagen has high tensile strength and is a non-toxic, easily absorbable, biodegradable, and biocompatible material. Therefore, it has been used for many medical applications such as in treatment for tissue infection, drug delivery systems, and gene therapy. Silk fibroin: Silk Fibroin (SF) is another protein rich biopolymer that can be obtained from different silkworm species, such as the mulberry worm Bombyx mori. In contrast to collagen, SF has a lower tensile strength but has strong adhesive properties due to its insoluble and fibrous protein composition. In recent studies, silk fibroin has been found to possess anticoagulation properties and platelet adhesion. Silk fibroin has been additionally found to support stem cell proliferation in vitro. Gelatin: Gelatin is obtained from type I collagen consisting of cysteine, and produced by the partial hydrolysis of collagen from bones, tissues and skin of animals. There are two types of gelatin, Type A and Type B. Type A collagen is derived by acid hydrolysis of collagen and has 18.5% nitrogen. Type B is derived by alkaline hydrolysis containing 18% nitrogen and no amide groups. Elevated temperatures cause the gelatin to melts and exists as coils, whereas lower temperatures result in coil to helix transformation.
Nobelium (102No) is a synthetic element, and thus a standard atomic weight cannot be given. Like all synthetic elements, it has no stable isotopes. The first isotope to be synthesized (and correctly identified) was 254No in 1966. There are fourteen known radioisotopes, which are 248No to 260No and 262No, and many isomers. The longest-lived isotope is 259No with a half-life of 58 minutes. The longest-lived isomer is 251m1No with a half-life of 1.02 seconds.
== Description == Eupolyphaga sinensis is often described as a wingless cockroach, this however is not entirely true. E. sinensis is a sexually dimorphic species, with the females being wingless, while the males are winged. Females are generally larger in size and darker in color than males. Within their range E. sinensis display significant size differences based on temperature and latitude. Body size of both males and females increase at high and low latitudes, with those found at an intermediate range being smaller. This body size difference is a result of genetic differentiation between populations, being adapted to their native climate.
Sources: en.wikipedia.org
=== Metropolis-coupled MCMC === Metropolis-coupled MCMC algorithm (MC³) has been proposed to solve a practical concern of the Markov chain moving across peaks when the target distribution has multiple local peaks, separated by low valleys, are known to exist in the tree space. This is the case during heuristic tree search under maximum parsimony (MP), maximum likelihood (ML), and minimum evolution (ME) criteria, and the same can be expected for stochastic tree search using MCMC. This problem will result in samples not approximating correctly to the posterior density. The (MC³) improves the mixing of Markov chains in presence of multiple local peaks in the posterior density. It runs multiple (m) chains in parallel, each for n iterations and with different stationary distributions
On 10 February 2021, Camille took part in a demonstration near the Élysée with politicians and activists including Matthieu Orphelin, Cécile Duflot, Marie Toussaint and Cyril Dion. See denounced the "lack of courage" from President Emmanuel Macron, who, according to her, "unraveled" the proposals of the Citizens Convention for Climate when drafting the 2021 loi Climat (Climate Law). On 16 June 2021, she announced that, alongside activist Cyril Dion and MEP Pierre Larrouturou, she was filing a complaint against Jean Castex and four other ministers (Bruno Le Maire, Barbara Pompili, Emmanuelle Wargon and Jean-Baptiste Djebbari) for their inaction in the face of climate change. The French State having already been condemned on numerous occasions (most notably by the Affaire du siècle campaign), they argued that taking individual ministers to court would be a more effective action. Camille is also engaged in campaigns against greenhouse gas emissions, in particular the EACOP, the world's largest heated oil pipeline planned in East Africa by TotalEnergies and the Lützerath mining site in Germany, as well as the exploitation of the seabed. In May 2023, she published Pour un soulèvement écologique : dépasser notre impuissance collective (For an Ecological Uprising: Overcoming our Collective Helplessness). In October 2023, she joined the fight against the planned A69 motorway linking Castres (Tarn) to Toulouse.
Dubnium is a synthetic chemical element; it has symbol Db and atomic number 105. It is highly radioactive: the most stable known isotope, dubnium-268, has a half-life of about 16 hours. This greatly limits extended research on the element. Dubnium does not occur naturally on Earth and is produced artificially. The Soviet Joint Institute for Nuclear Research (JINR) claimed the first discovery of the element in 1968, followed by the American Lawrence Berkeley Laboratory in 1970. Both teams proposed their names for the new element and used them without formal approval. The long-standing dispute was resolved in 1993 by an official investigation of the discovery claims by the Transfermium Working Group, formed by the International Union of Pure and Applied Chemistry and the International Union of Pure and Applied Physics, resulting in credit for the discovery being officially shared between both teams. The element was formally named dubnium in 1997 after the town of Dubna, the site of the JINR. Theoretical research establishes dubnium as a member of group 5 in the 6d series of transition metals, placing it under vanadium, niobium, and tantalum. Dubnium should share most properties, such as its valence electron configuration and having a dominant +5 oxidation state, with the other group 5 elements, with a few anomalies due to relativistic effects. A limited investigation of dubnium chemistry has confirmed this.
There are nine subtilisin homologs in mammals; in addition to proprotein convertase 1 and 2, other members of this enzyme family include furin, PACE4, PC4, PC5/6, PC7/8, PCSK9, and SKI1/S1P. Proprotein convertase 1 converts prorenin into renin.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.